New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 3, 2014
05:47 EDTPFE, MCPStocks with implied volatility movement; PFE MCP
Stocks with implied volatility movement; Pfizer (PFE) 16, Molycorp (MCP) 91 according to iVolatility.
News For PFE;MCP From The Last 14 Days
Check below for free stories on PFE;MCP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 15, 2014
09:25 EDTPFEJPMorgan biotech analysts hold an analyst/industry conference call
Analysts assess Pfizer's M&A options on an Analyst/Industry conference call to be held on September 15 at 10 am.
07:27 EDTPFEIBC Life Sciences to hold a conference
Subscribe for More Information
07:27 EDTPFEPfizer acquisition could drive shares higher, says JPMorgan
Subscribe for More Information
September 14, 2014
13:32 EDTPFEPfizer shares look cheap, Barron's says
Subscribe for More Information
September 12, 2014
10:32 EDTPFEPfizer CEO says company still open to inversion deal, FT says
Pfizer (PFE) CEO Ian Read said U.S. rhetoric against tax inversions has been "political theater" ahead of midterm elections and made clear that his company is still open to a potential tax-saving acquisition, according to Financial Times, which added Read's comment about not being “held hostage” over price would likely be read as a signal the company might look elsewhere after being rebuffed by AstraZeneca (AZN). The Fly notes that Bloomberg previously reported, citing people familiar with the matter, that Pfizer is looking at targets other than AstraZeneca, including Actavis (ACT). Shares of Actavis trading in New York are up 2% this morning. Reference Link
September 11, 2014
18:35 EDTMCPOn The Fly: After Hours Movers
Subscribe for More Information
17:00 EDTMCPMolycorp announces closing of $400M financing arrangement
Molycorp, Inc. announced the successful close of its previously announced $400M financing arrangement with certain investment vehicles affiliated with Oaktree Capital Management, L.P. Under the arrangement, Oaktree will provide Molycorp and certain of the company's subsidiaries with up to $400M in secured financing through credit facilities and the sale and leaseback of certain equipment at the company's Mountain Pass facility. $250M of the financings has now been funded, with the remaining $150M available until April 30, 2016 if Molycorp achieves consolidated adjusted EBITDA of not less than $20.0M per quarter for two consecutive fiscal quarters, and production volume at its Mountain Pass facility of at least 4,000 metric tons per quarter for two consecutive fiscal quarters.
September 8, 2014
07:15 EDTPFEIBC Life Sciences to hold a conference
10th Annual Cell Line Development & Engineering Conference to be held in Berkeley, California on September 8-10.
September 5, 2014
16:01 EDTMCPOptions Update; September 5, 2014
Subscribe for More Information
12:42 EDTMCPStocks with increasing options volume
Stocks with increasing options volume: VALE MCP KORS WAG GM PCLN
September 4, 2014
16:05 EDTPFEPfizer granted orphan status for sickle cell disease drug
Subscribe for More Information
07:23 EDTPFEAstraZeneca called for inversion clamp down as part of defense, WSJ says
Amid its defense against an unsolicited takeover bid from rival Pfizer (PFE), AstraZeneca (AZN) hired advisers with close ties to the Obama administration, who made calls to senior administration officials urging a clamp down on tax inversions, said The Wall Street Journal, citing people familiar with the previously undisclosed calls. Reference Link
September 3, 2014
11:30 EDTPFEPfizer has conference call hosted by Bernstein
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use